Analyst Price Target is GBX 279
▲ +64.50% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Syncona in the last 3 months. The average price target is GBX 279, with a high forecast of GBX 279 and a low forecast of GBX 279. The average price target represents a 64.50% upside from the last price of GBX 169.60.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Syncona. This Buy consensus rating has held steady for over two years.
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.